Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective

Infection Ecology and Epidemiology

Volumn 4, Issue 1, 2014, Pages

  Brolund, Alma ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Antibiotic resistance; E. coli; Epidemiology; Extended spectrum b lactamase; K. pneumoniae

Indexed keywords

AZTREONAM; BETA LACTAMASE CTX M; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BLOODSTREAM INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; DENMARK; DISEASE SEVERITY; ENTEROBACTERIACEAE INFECTION; ESBL GENE; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GENE INDUCTION; HORIZONTAL GENE TRANSFER; HUMAN; INFECTION CONTROL; INFECTION RISK; MICROBIOLOGICAL EXAMINATION; MOLECULAR CLONING; NONHUMAN; NORWAY; PLASMID; PREVALENCE; REVIEW; RISK FACTOR; URINARY TRACT INFECTION;

EID: 84987902531     PISSN: None     EISSN: 20008686     Source Type: Journal    
DOI: 10.3402/iee.v4.24555     Document Type: Review

References (65)

1. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-86.
2. Giske CG, Sundsfjord AS, Kahlmeter G, Woodford N, Nordmann P, Paterson DL, et al. Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother 2009; 63: 1-4.
3. Birkett CI, Ludlam HA, Woodford N, Brown DF, Brown NM, Roberts MT, et al. Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum betalactamases. J Med Microbiol 2007; 56: 52-5.
4. D'Andrea MM, Arena F, Pallecchi L, Rossolini GM. CTX-Mtype beta-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol 2013; 303: 305-17.
5. Abraham S, Chapman TA, Zhang R, Chin J, Mabbett AN, Totsika M, et al. Molecular characterization of Escherichia coli strains that cause symptomatic and asymptomatic urinary tract infections. J Clin Microbiol 2012; 50: 1027-30.
6. Madigan MT, Martinko JM, Parker J. Brock biology of microorganisms. 10th ed. NJ, USA: Pearson Education, Inc., Upper Saddleiver; 2003.
7. Brolund A, Edquist PJ, Makitalo B, Olsson-Liljequist B, Soderblom T, Wisell KT, et al. Epidemiology of extendedspectrum beta-lactamase-producing Escherichia coli in Sweden 2007-2011. Clin Microbiol Infect 2014; 20: O344-52.
8. de Kraker ME, Davey PG, Grundmann H, BURDEN study group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 2011; 8: e1001104.
9. Giske CG, Monnet DL, Cars O, Carmeli Y, ReAct-Action on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 2008; 52: 813-21.
10. Peralta G, Lamelo M, Alvarez-Garcia P, Velasco M, Delgado A, Horcajada JP, et al. Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect Dis 2012; 12: 245.
11. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
12. Canton R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006; 9: 466-75.
13. Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, et al. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway. APMIS 2009; 117: 526-36.
14. Olesen B, Hansen DS, Nilsson F, Frimodt-Moller J, Leihof RF, Struve C, et al. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J Clin Microbiol 2013; 51: 1779-85.
15. Forssten SD, Kolho E, Lauhio A, Lehtola L, Mero S, Oksaharju A, et al. Emergence of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland. Clin Microbiol Infect 2010; 16: 1158-61.
16. Nyberg SD, Osterblad M, Hakanen AJ, Huovinen P, Jalava J, Resistance TF. Detection and molecular genetics of extendedspectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. Scand J Infect Dis 2007; 39: 417-24.
17. Baraniak A, Fiett J, Sulikowska A, Hryniewicz W, Gniadkowski M. Countrywide spread of CTX-M-3 extendedspectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother 2002; 46: 151-9.
18. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59: 165-74.
19. Naseer U, Sundsfjord A. The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist 2011; 17: 83-97.
20. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, et al. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis 2013; 56: 641-8.
21. Chong Y, Shimoda S, Yakushiji H, Ito Y, Miyamoto T, Kamimura T, et al. Community spread of extended-spectrum beta-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan. J Med Microbiol 2013; 62: 1038-43.
22. Xia S, Fan X, Huang Z, Xia L, Xiao M, Chen R, et al. Dominance of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China. PLoS One 2014; 9: e100707.
23. Muzaheed, Doi Y, Adams-Haduch JM, Endimiani A, Sidjabat HE, Gaddad SM, et al. High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India. J Antimicrob Chemother 2008; 61: 1393-4.
24. Bennett PM. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol 2008; 153: S347-57.
25. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 2014; 27: 543-74.
26. Brolund A, Edquist PJ, Makitalo B, Olsson-Liljequist B, Soderblom T, Tegmark Wisell K, et al. Epidemiology of ESBL-producing Escherichia coli in Sweden 2007-2011. Clin Microbiol Infect, 2013; 20(6): O344-52.
27. Andrade LN, Vitali L, Gaspar GG, Bellissimo-Rodrigues F, Martinez R, Darini AL. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTXM-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J Clin Microbiol 2014; 52: 2530-5.
28. Lytsy B, Sandegren L, Tano E, Torell E, Andersson DI, Melhus A. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 2008; 116: 302-8.
29. Rettedal S, Lohr IH, Natas O, Giske CG, Sundsfjord A, Oymar K. First outbreak of extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae in a Norwegian neonatal intensive care unit; associated with contaminated breast milk and resolved by strict cohorting. APMIS 2012; 120: 612-21.
30. Novick RP. Plasmid incompatibility. Microbiol Rev 1987; 51: 381-95.
31. Couturier M, Bex F, Bergquist PL, Maas WK. Identification and classification of bacterial plasmids. Microbiol Rev 1988; 52: 375-95.
32. Carattoli A. Plasmids in Gram negatives: molecular typing of resistance plasmids. Int J Med Microbiol 2011; 301: 654-8.
33. Carattoli A. Plasmids and the spread of resistance. Int J Med Microbiol 2013; 303: 298-304.
34. Brolund A, Franzen O, Melefors O, Tegmark-Wisell K, Sandegren L. Plasmidome-analysis of ESBL-producing Escherichia coli using conventional typing and high-throughput sequencing. PLoS One 2013; 8: e65793.
35. Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 2010; 65: 2518-29.
36. Bengtsson S, Naseer U, Sundsfjord A, Kahlmeter G, Sundqvist M. Sequence types and plasmid carriage of uropathogenic Escherichia coli devoid of phenotypically detectable resistance. J Antimicrob Chemother 2012; 67: 69-73.
37. Helldal L, Karami N, Floren K, Welinder-Olsson C, Moore ER, Ahren C. Shift of CTX-M genotypes has determined the increased prevalence of extended-spectrum beta-lactamaseproducing Escherichia coli in south-western Sweden. Clin Microbiol Infect 2013; 19: E87-90.
38. Ostholm-Balkhed A, Tarnberg M, Nilsson M, Johansson AV, Hanberger H, Monstein HJ, et al. Prevalence of extendedspectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden. Scand J Infect Dis 2010; 42: 831-8.
39. Stromdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I. Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis 2011; 30: 1159-62.
40. Kaarme J, Molin Y, Olsen B, Melhus A. Prevalence of extendedspectrum beta-lactamase-producing Enterobacteriaceae in healthy Swedish preschool children. Acta Paediatr 2013; 102: 655-60.
41. Hansen F, Olsen SS, Heltberg O, Justesen US, Fuglsang-Damgaard D, Knudsen JD, et al. Characterization of thirdgeneration cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark. Microb Drug Resist 2014; 20: 316-24.
42. NORM/NORM-VET 2012. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromsø/Oslo 2013.
43. Castanheira M, Farrell SE, Deshpande LM, Mendes RE, Jones RN. Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother 2013; 57: 3012-20.
44. Simner PJ, Zhanel GG, Pitout J, Tailor F, McCracken M, Mulvey MR, et al. Prevalence and characterization of extendedspectrum beta-lactamase-and AmpC beta-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011; 69: 326-34.
45. Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010; 23: 320-6.
46. Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Lundborg CS. High prevalence of extended-spectrum betalactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Infect Drug Resist 2012; 5: 65-73.
47. SWEDRES-SVARM 2012. Use of antimicrobials and occurrence of antimicrobial resistance in Sweden. 2012.
48. Tangden T, Cars O, Melhus A, Lowdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-8.
49. Lausch KR, Fuursted K, Larsen CS, Storgaard M. Colonisation with multi-resistant Enterobacteriaceae in hospitalised Danish patients with a history of recent travel: a cross-sectional study. Travel Med Infect Dis 2013; 11: 320-3.
50. March A, Aschbacher R, Pagani E, Sleghel F, Soelva G, Hopkins KL, et al. Changes in colonization of residents and staff of a long-term care facility and an adjacent acute-care hospital geriatric unit by multidrug-resistant bacteria over a four-year period. Scand J Infect Dis 2014; 46: 114-22.
51. Jadhav S, Sahasrabudhe T, Kalley V, Gandham N. The microbial colonization profile of respiratory devices and the significance of the role of disinfection: a blinded study. J Clin Diagn Res 2013; 7: 1021-6.
52. Deege MP, Paterson DL. Reducing the development of antibiotic resistance in critical care units. Curr Pharm Biotechnol 2011; 12: 2062-9.
53. Trott D. β-Lactam resistance in gram-negative pathogens isolated from animals. Curr Pharm Des 2013; 19: 239-49.
54. Reuland EA, Al Naiemi N, Raadsen SA, Savelkoul PH, Kluytmans JA, Vandenbroucke-Grauls CM. Prevalence of ESBL-producing Enterobacteriaceae in raw vegetables. Eur J Clin Microbiol Infect Dis 2014; [Epub ahead of print].
55. Egervarn M, Borjesson S, Byfors S, Finn M, Kaipe C, Englund S, et al. Escherichia coli with extended-spectrum beta-lactamases or transferable AmpC beta-lactamases and Salmonella on meat imported into Sweden. Int J Food Microbiol 2014; 171: 8-14.
56. Tschudin-Sutter S, Frei R, Stephan R, Hachler H, Nogarth D, Widmer AF. Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: a threat from the kitchen. Infect Control Hosp Epidemiol 2014; 35: 581-4.
57. Alsterlund R, Axelsson C, Olsson-Liljequist B. Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli. Scand J Infect Dis 2012; 44: 51-4.
58. Lohr IH, Rettedal S, Natas OB, Naseer U, Oymar K, Sundsfjord A. Long-term faecal carriage in infants and intrahousehold transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak. J Antimicrob Chemother 2013; 68: 1043-8.
59. Tham J, Walder M, Melander E, Odenholt I. Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis 2012; 44: 573-7.
60. Titelman E, Hasan CM, Iversen A, Naucler P, Kais M, Kalin M, et al. Faecal carriage of extended-spectrum betalactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors. Clin Microbiol Infect 2014; [Epub ahead of print].
61. Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Canton R, et al. High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol 2008; 46: 2796-9.
62. Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, Diaz de Alba P, Pascual A. Faecal carriage of extended-spectrum betalactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008; 62: 1142-9.
63. Lo WU, Ho PL, Chow KH, Lai EL, Yeung F, Chiu SS. Fecal carriage of CTXM type extended-spectrum beta-lactamaseproducing organisms by children and their household contacts. J Infect 2010; 60: 286-92.
64. Tande D, Boisrame-Gastrin S, Munck MR, Hery-Arnaud G, Gouriou S, Jallot N, et al. Intrafamilial transmission of extendedspectrum-beta-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children. J Antimicrob Chemother 2010; 65: 859-65.
65. Cottell JL, Webber MA, Piddock LJ. Persistence of transferable extended-spectrum-beta-lactamase resistance in the absence of antibiotic pressure. Antimicrob Agents Chemother 2012; 56: 4703-6.